Overactive Bladder - Results from #400

The three-year evolution of overactive bladder syndrome in community-dwelling female residents aged 40 years and above. June 26, 2022

Synchronous Telemedicine Model in Urogynecology: Are Patients Willing to Continue Telemedicine in the Post-COVID-19 Pandemic Era? June 26, 2022

Does COVID-19 Vaccination Cause Storage Lower Urinary Tract Symptoms? June 19, 2022

Does metabolic syndrome influence the efficacy of mirabegron treatment in female patients with overactive bladder? June 19, 2022

The association between overactive bladder and fibromyalgia: A systematic review and meta-analysis. June 19, 2022

UroViu Launches New Single-Use Hysteroscope June 15, 2022

Transcutaneous Tibial Nerve Stimulation in the Management of Overactive Bladder: A Scoping Review. June 12, 2022

Dementia Associated with Anticholinergic Drugs Used for Overactive Bladder: A Nested-Case Control Study Using the French National Medical-Administrative Database. June 12, 2022

Vibegron for the Treatment of Patients with Dry and Wet Overactive Bladder: A Subgroup Analysis from the EMPOWUR Trial. June 12, 2022

Biofeedback-assisted pelvic floor muscle training and pelvic electrical stimulation in women with overactive bladder: A systematic review and meta-analysis of randomized controlled trials. June 12, 2022

Bright Uro Launches with $6 Million in Seed Financing and Grant from National Institutes of Health June 9, 2022

A Multi-Center, Randomized, Blind, Controlled Clinical Trial of the Safety and Efficacy of Micro Radio Frequency Therapy System for the Treatment of Overactive Bladder. June 5, 2022

Third-line therapy for overactive bladder in the elderly: Nuances and considerations. June 5, 2022

Sacral Neuromodulation Using a Novel Device with a Six-contact-point Electrode for the Treatment of Patients with Refractory Overactive Bladder: A Multicenter, Randomized, Single-blind, Parallel-control Clinical Trial. May 29, 2022

Home-based transcutaneous tibial nerve stimulation for overactive bladder syndrome: a randomized, controlled study. May 29, 2022

First North American experience of propiverine use in children with overactive bladder. May 29, 2022

Oral Phenazopyridine vs Intravesical Lidocaine for Bladder OnabotulinumtoxinA Analgesia: A Randomized Controlled Trial (OPIL). May 22, 2022

Impact of Duration of Antibiotic Prophylaxis on Incidence of UTI after OnabotulinumtoxinA Injection. May 22, 2022

Associations between the Patient Perception of Bladder Condition score and overactive bladder syndrome symptoms at baseline and upon treatment. May 22, 2022

Evaluating and understanding combination therapy decision drivers for the treatment of overactive bladder in the United States. May 22, 2022

Page 21 of 122